More than a quarter of patients with renal cell carcinoma on active surveillance experience spontaneous tumor regression, researchers report.

Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...

Arizona children with autism risk losing therapy services due to a contract dispute between an insurer and a local autism ...

A dispute between an Arizona Medicaid insurer and a large autism therapy provider could leave hundreds of patients searching ...

Clinical data must be strong enough to exclude regression to the mean.

A judge has temporarily paused North Carolina’s cuts to Medicaid reimbursement for treatment of children with autism, halting the changes statewide while a lawsuit over the cuts proceeds. The state’s ...

Researchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer Center, and RWJBarnabas Health, along with colleagues from the National ...

This third of five exclusive episodes explores how clinicians can navigate newly approved MASH therapies -- resmetirom (Rezdiffra) and semaglutide (Wegovy) -- and how to tailor treatment choices based ...

Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...

Lunai Bioworks (LNAI) has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both ...

Morgan showed the video to her doctor, and following tests, Lydia was diagnosed with Sanfilippo syndrome B — often called ...